NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Antiviral Activity


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Concert Pharmaceuticals Initiates Phase 1b Clinical Trial of CTP-518, Protease Inhibitor for Treatment of HIV
2009 NOV 23 ... certain key hydrogen atoms of atazanavir with deuterium. In preclinical studies, the antiviral potency of atazanavir was fully retained but with markedly slower hepatic metabolism, ... structure, deuterium-containing compounds are expected to have similar pharmacological activity as their hydrogen analogs. However, as deuterium is heavier than hydrogen, it therefore ...
Subject: Concert Pharmaceuticals, Inc.
Price: $3.00
*
Inhibitex Reports Third Quarter 2009 Financial Results
2009 NOV 28 ... continue to make progress on all fronts, including the advancement of our differentiated antiviral development programs and most recently, the completion of a financing that we believe ... to enroll patients in its Phase II clinical trial to evaluate the safety and biologic activity of FV-100 for the treatment of shingles. INX -189 -During the third quarter, the Company ...
Subject: Inhibitex, Inc.
Price: $3.00
*
Kineta, University of Washington Partner on NIH-Funded Project to Develop Vaccine Immune Boosters
2009 NOV 23 ... is a discovery-stage biotechnology company focused on the development of new types of antiviral and autoimmune drugs. The Kineta team has a track record of developing novel drug ... to vaccines, have the potential to substantially accelerate, prolong or enhance the activity of the vaccines. Kineta is a discovery-stage biotechnology company focused ...
Subject: Kineta, Inc.
Price: $3.00
*
MicroDose Therapeutx Acquires ViroPharma Portfolio of Investigational Compounds for Treatment of Respiratory Syncytial Virus RSV
2009 NOV 23 ... fusion inhibitor, now called MDT-637. This highly potent compound has demonstrated antiviral activity in preclinical studies in both prophylaxis and treatment, and was generally well ...
Subject: MicroDose Therapeutx Inc.
Price: $3.00
*
New chemistry research from M. Sala et al outlined
2009 NOV 27 ... concluded: "The prepared family of the target nucleosides was tested for cytostatic and antiviral activity."Sala and colleagues published their study in Tetrahedron (Norbornane as ...
Subject: Chemistry
Price: $3.00
*
New findings from T.A. Kirschberg and co-authors in the area of RNA research published
2009 NOV 23 ... site. Inhibition of enzymatic activity was measured in a biochemical assay, but no antiviral effect was observed," wrote T.A. Kirschberg and colleagues. The ...
Subject: RNA Research
Price: $3.00
*
New virology study results from C. Dellanno et al described
2009 NOV 23 ... for testing and biosafety requirements necessary to safely handle it, In this study, the antiviral activity of standard household products was assayed against murine hepatitis virus (MHV), as a ...
Subject: Virology
Price: $3.00
*
NexBio(R) Presents Data Showing Anti-Asthma Activity of DAS181 (Fludase(R)*) at ACAAI 2009
2009 NOV 23 ... Affairs. "These data support the unique dual activities of DAS181. Because of its antiviral and anti-asthmatic properties, DAS181 may provide an alternative influenza treatment ... parainfluenza. NexBio has recently announced the publication of two articles describing activity in non-clinical models of DAS181 for Pandemic Influenza A(H1N1) and for influenza ...
Subject: Asthma
Price: $3.00
*
Research on multiple sclerosis published by scientists at Technical University of Munich
2009 NOV 23 ... treatment of multiple sclerosis (MS). it is believed that immunomodulatory rather than antiviral activity of interferon beta is responsible for disease amelioration. The impact of interferon ...
Subject: Multiple Sclerosis
Price: $3.00
*
Researchers from Indiana University publish new studies and findings in the area of pandemics
2009 NOV 17 ... disease parameter values. We also studied the effect of systematic therapeutic use of antiviral drugs on the epidemic timeline. The analysis shows the potential for an early epidemic ... scenarios for the future unfolding of the pandemic and the estimate of pandemic activity peaks in the different hemispheres. We provide estimates for the number of ...
Subject: Pandemics
Price: $3.00
*
Studies conducted at National Cancer Center Hospital on acinar cell cancer therapy recently published
2009 NOV 23 ... Therapy, Acinar Cell Cancer, Acinar Cell Carcinoma, Antimetabolite, Antineoplastic, Antiviral, Clinical Oncology, Gastroenterology, Gemcitabine, Immunosuppressant, Oncology, ... by gemcitabine. On the other hand, fluoropyrimidine-based chemotherapy may have some activity against this tumor, because one of the three patients who received S-1 as second-line ...
Subject: Acinar Cell Cancer Therapy
Price: $3.00
*
Study data from University of Paris update understanding of cancer
2009 NOV 23 ... Country:France, Anticancer Therapy, Antimetabolite, Antineoplastic, Antiviral, Apoptosis, Clinical Trial Research, Clinical Trials, Enzymes, Gemcitabine, ... with considerable resistance to deamination and significantly higher anticancer activity compared with gemcitabine in an intravenously grafted tumor model in mice. To further ...
Subject: Cancer
Price: $3.00
*
Study findings from University of Central Florida provide new insights into pancreatic cancer
2009 NOV 16 ... USA. Keywords: United States, Orlando, Antimetabolite, Antineoplastic, Antiviral, Apoptosis, Experimental Design, Gastroenterology, Gemcitabine, Immunosuppressant, ... alone or in combination with gemcitabine, and the therapeutic efficacy and biological activity of these drug combinations were investigated," investigators in the United States ...
Subject: Pancreatic Cancer
Price: $3.00
*
Study results from University of Zurich in the area of HIV/AIDS therapy published
2009 NOV 23 ... (RAMs) were investigated by analysing 6072 genotypic tests." "The antiviral activity of ETV was predicted using different interpretation systems: International AIDS ...
Subject: HIV/AIDS Therapy
Price: $3.00
*
Texas State University Prepares for Phase 2 Research on the Potential New Cancer and HIV Fighting ALKA-V6 Compound
2009 NOV 16 ... glutathione, superoxide dismutase and catalase. ALKA-V6 was also very effective in its antiviral activities, and at very low doses it was highly effective in inhibiting viral ... product has been imputed to have several health benefits including anti-microbial activity, bone remodeling and joint health promoting functions as well as chemotherapeutic ...
Subject: HIV/AIDS
Price: $3.00
*
Twice Daily Oral Medication Shows Promise in Treating Patients with Hepatitis C
2009 NOV 16 ... to demonstrate that an IFN-free, twice daily, combination DAA regimen produces similar antiviral activity compared to triple therapy (SOC plus protease) over 2 weeks of treatment," said Dr. ...
Subject: Hepatitis C Virus
Price: $3.00
*
USU scientists report major advance in human antibody therapy against deadly Nipah virus
2009 NOV 16 ... or livestock," said Dr. Broder. "This fully-human monoclonal antibody is the first antiviral agent against the Nipah and Hendra viruses that has a genuine potential for human ... infection in a similar manner should be possible, given the very strong cross-reactive activity this antibody has against Hendra virus," said Deborah Middleton, D.V.M., Ph.D., who ...
Subject: Henry M. Jackson Foundation for the Advancement of Military Medicine
Price: $3.00
*
ZymoGenetics Reports Third Quarter 2009 Financial Results
2009 NOV 16 ... trial results for PEG-Interferon lambda with positive results for tolerability and antiviral activity, and the Phase 2 clinical trial is underway, triggering a $70.0 million milestone ...
Subject: ZymoGenetics, Inc.
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login